申请人:Pharmacia Corporation
公开号:US20020183362A1
公开(公告)日:2002-12-05
Methods of treating cyclooxygenase-2 mediated disorders comprising administering to a subject a therapeutically effective amount of one or more 2-fluorobenzenesulfonyl compounds corresponding to Formula I:
1
wherein A, R
1
, R
2
, and R
3
are as described in the specification, and novel 2 fluorobenzenesulfonyl compounds within Formula I.
治疗环氧合酶-2介导的疾病的方法包括向受试者施用与公式I中对应的一种或多种2-氟苯磺酰化合物的治疗有效剂量:1其中A、R1、R2和R3如规范中所述,并且公式I内的新型2-氟苯磺酰化合物。